title: Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case report.
abstract: Interstitial pneumonitis is a rare but potentially fatal side effect occurring from 2 weeks to 16 weeks after the initiation of treatment with pegylated interferon alpha and ribavirin for chronic hepatitis C.Herein, we present a 68-year-old man with chronic hepatitis C virus infection who developed interstitial pneumonitis association with pegylated interferon after 36 weeks initiation of pegylated interferon-alpha and ribavirin therapy. He did not recover after discontinuation of pegylated interferon/ribavirin and improved by steroid therapy.
authors.affiliation: Department of Gastroenterology, Marmara University School of Medicine, Istanbul, Turkey. ozlenatug@hotmail.com
authors.forename: Ozlen
authors.initials: O
authors.lastname: Atug
authors.forename: Hakan
authors.initials: H
authors.lastname: Akin
authors.forename: Yesim Ozen
authors.initials: YO
authors.lastname: Alahdab
authors.forename: Berrin
authors.initials: B
authors.lastname: Ceyhan
authors.forename: Nurdan
authors.initials: N
authors.lastname: Tozun
authors.forename: Osman
authors.initials: O
authors.lastname: Ozdogan